Skip to main content

Peer Review reports

From: The impact of COVID-19 on aflibercept treatment of neovascular AMD in Sweden – data from the Swedish Macula Register

Original Submission
11 Sep 2023 Submitted Original manuscript
24 Oct 2023 Reviewed Reviewer Report - Florian Baudin
2 Nov 2023 Reviewed Reviewer Report
30 Nov 2023 Author responded Author comments - Isac Wickman
Resubmission - Version 2
30 Nov 2023 Submitted Manuscript version 2
1 Dec 2023 Author responded Author comments - Isac Wickman
Resubmission - Version 3
1 Dec 2023 Submitted Manuscript version 3
10 Dec 2023 Reviewed Reviewer Report
23 Jan 2024 Author responded Author comments - Isac Wickman
Resubmission - Version 4
23 Jan 2024 Submitted Manuscript version 4
Publishing
24 Jan 2024 Editorially accepted
30 Jan 2024 Article published 10.1186/s12886-024-03326-8

You can find further information about peer review here.

Back to article page